ZK-261991
- Product NameZK-261991
- CAS886563-25-3
- CBNumberCB02628541
- MFC24H25N7O2
- MW443.5
- MDL NumberMFCD25976709
- MOL File886563-25-3.mol
Chemical Properties
| storage temp. | Store at -20°C |
| solubility | Soluble in DMSO |
ZK-261991 Chemical Properties,Usage,Production
Uses
ZK-261991 is an orally active VEGFR tyrosine kinase inhibitor with an IC50 of 5 nM for VEGFR2.in vivo
ZK991 results in a significantly reduced recruitment of CD11b+ and LYVE-1+ cells into the murine cornea. ZK991 significantly improves the graft survival rate after corneal transplantation[1].
IC 50
VEGFR2: 5 nM (IC50)References
[1] Deniz Hos, et al. Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation. Investigative Ophthalmology & Visual Science May 2008, Vol.49, 1836-184ZK-261991 Suppliers
Global(11)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | 32430 | 58 | ||
| +1-781-999-5354; | support@targetmol.com | 38999 | 58 | ||
| 13564774135 | marketing@targetmol.com | 19950 | 58 | ||
| 400-025-6535 | sales@adooq.cn | 6207 | 58 | ||
| 51288865780 | sales@biosynth.com | 6031 | 58 | ||
| 4008200310 15002144251 | marketing@tsbiochem.com | 24951 | 58 | ||
| 16314854226 | info@bocsci.com | 0 | 65 | ||
| 021-58955995 | sales@medchemexpress.com | 6387 | 58 | ||
| 13348960310 13348960310 | 3003867561@qq.com | 10172 | 58 |